Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - TOTAL CURRENT LIABILITIES
Total Current Liabilities INZY - Inozyme Pharma, Inc.
14.7 M
LAST VALUE
12.36%
2 YEAR CAGR
43.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR